Teza Capital Management LLC Sells 6,672 Shares of Encompass Health Corporation $EHC

Key Points

• Teza Capital Management LLC reduced its stake in Encompass Health Corporation by 54.6%, maintaining ownership of 5,538 shares valued at approximately $561,000.
• Encompass Health's quarterly earnings outperformed expectations, reporting $1.40 EPS compared to the consensus estimate of $1.20 EPS.
• The company declared an increase in its quarterly dividend to $0.19 from the previous $0.17, with an ex-dividend date set for October 1st.

Teza Capital Management LLC lowered its stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 54.6% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 5,538 shares of the company's stock after selling 6,672 shares during the period. Teza Capital Management LLC's holdings in Encompass Health were worth $561,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Millennium Management LLC boosted its stake in Encompass Health by 38.4% during the 1st quarter. Millennium Management LLC now owns 92,197 shares of the company's stock valued at $9,338,000 after purchasing an additional 25,574 shares during the last quarter. Hancock Whitney Corp boosted its stake in Encompass Health by 6.6% during the 1st quarter. Hancock Whitney Corp now owns 9,564 shares of the company's stock valued at $969,000 after purchasing an additional 596 shares during the last quarter. AlTi Global Inc. acquired a new position in Encompass Health during the 1st quarter valued at about $1,908,000. Adage Capital Partners GP L.L.C. boosted its stake in shares of Encompass Health by 11.5% in the 1st quarter. Adage Capital Partners GP L.L.C. now owns 205,162 shares of the company's stock worth $20,779,000 after buying an additional 21,100 shares during the last quarter. Finally, Dark Forest Capital Management LP boosted its stake in shares of Encompass Health by 611.6% in the 1st quarter. Dark Forest Capital Management LP now owns 51,981 shares of the company's stock worth $5,265,000 after buying an additional 44,676 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Encompass Health Stock Performance

Encompass Health stock traded down $0.75 during trading on Friday, hitting $126.05. The stock had a trading volume of 311,384 shares, compared to its average volume of 802,852. The stock's 50 day moving average is $117.36 and its two-hundred day moving average is $112.58. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 1 year low of $87.85 and a 1 year high of $127.15. The stock has a market cap of $12.70 billion, a price-to-earnings ratio of 24.65, a price-to-earnings-growth ratio of 2.18 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Monday, August 4th. The company reported $1.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.20 by $0.20. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The business had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. During the same quarter in the previous year, the firm posted $1.11 EPS. The business's revenue for the quarter was up 12.0% compared to the same quarter last year. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. As a group, analysts predict that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Wednesday, October 1st. This is a positive change from Encompass Health's previous quarterly dividend of $0.17. Encompass Health's payout ratio is presently 13.31%.

Insider Transactions at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the business's stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the sale, the executive vice president owned 18,846 shares of the company's stock, valued at $2,329,177.14. The trade was a 5.13% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 2.00% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Truist Financial boosted their target price on Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a research note on Thursday, August 14th. KeyCorp boosted their target price on Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 27th. Bank of America boosted their target price on Encompass Health from $145.00 to $160.00 and gave the stock a "buy" rating in a research note on Wednesday. UBS Group boosted their target price on Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Finally, Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price objective on the stock in a research note on Thursday, June 5th. One research analyst has rated the stock with a Strong Buy rating and seven have issued a Buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $137.71.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.